Why is Venmax Drugs falling/rising?

As of 14-Jul, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, with its current price at 24.33, reflecting a rise of 0.47 or 1.97%. The stock has shown strong performance today, outperforming its sector by 1.07%, and has been on a consecutive gain streak for the last three days, accumulating a total return of 6.01% during this period. Additionally, the stock's delivery volume has significantly increased by 208.71% compared to the 5-day average, indicating rising investor participation. While the stock has declined by 12.39% over the past month, it has a year-to-date return of 34.87%, suggesting a strong overall performance despite recent volatility.
In the broader market context, the Sensex has declined by 1.42% over the past week, while Venmax's stock has gained 1.88%, indicating that it is outperforming the benchmark in the short term. This divergence suggests that investor sentiment towards Venmax is currently more positive compared to the overall market trend. However, it is important to note that the stock's performance over the past month has been weaker than the Sensex, which has gained 1.40%. The current liquidity of the stock, being sufficient for trading, further supports its recent upward movement, although no specific positive or negative factors were provided to elaborate on the underlying reasons for the stock's fluctuations.